LETMYLAN 2,5 MG TBL FLM 100

What is the maximum co-payment for LETMYLAN?

If the insurance company contributes, the maximum co-payment is 6 639,82 Kč. The maximum pharmacy price is 7 383,96 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does LETMYLAN have a counted co-payment set?

Yes, the medicine has a counted co-payment of 1 123,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

744,14 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

1) V adjuvanci u postmenopauzálních pacientek s karcinomem prsu je lékem první volby tamoxifen. Inhibitory aromatáz jsou hrazeny v případě:
a) kontraindikace tamoxifenu
b) u pacientek se středním a vysokým rizikem relapsu (dle St. Gallen)
c) po 2-3 letech podávání tamoxifenu (switch aplikace)
d) po 5 letech podávání tamoxifenu (prodloužená adjuvance)
2) v paliativní léčbě metastatického onemocnění je lékem první volby tamoxifen. Inhibitory aromatáz jsou hrazeny v případě kontraindikace tamoxifenu nebo při relapsu do jednoho roku po ukončení léčby tamoxifenem.

Rychlý přehled

Dosage form Tablets film-coated
Výdej Ne, lék nelze získat bez receptu.
Úhrada / doplatek / cena Ano, zkontrolujte ale specializaci předepisujícího lékaře níže (tzv. nedelegovatelná preskripce). Maximální doplatek: 6 639,82 Kč. Maximální cena: 7 383,96 Kč.
Kdo může předepsat clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
Složení More information about the composition can be found in the SPC, section 6.1.
Dostupnost / výpadek Ukončeno The latest report from the manufacturer is from 9. 11. 2023. Výroba byla ukončena s platností od 14. 11. 2023. The manufacturer lists medicines with the following code as a potential substitute: 0268940
Kód SÚKL 0234506

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe LETMYLAN?

  • clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology

What is the composition of LETMYLAN?

. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

  • Documents could not be found v lokální importní databázi.

Which medicines are similar to LETMYLAN?

The medicine belongs to ATC group L02BG04. Název skupiny není v lokální importní databázi dostupný.

Who manufactures LETMYLAN?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 9. 11. 2023. Production was terminated with effect from 14. 11. 2023. The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for LETMYLAN?

The medicine has code 0234506. Code details can be found here.

How many packs of LETMYLAN were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of LETMYLAN were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

Z čeho se skládá maximální cena léku?

The page was last updated on 22. 06. 2026

SIMILAR MEDICINES: